BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 06, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Vaccine technology derived from alphavirus replicons regulatory update

CHIR received U.S. Patent Nos. 6,015,686 and 6,015,694 covering alphavirus replicon-derived vaccine technology. Alphavirus replicons are gene delivery vectors that induce immunity...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >